Intracellular and plasma efavirenz concentrations in HIV-infected patients switching from successful protease inhibitor-based highly active antiretroviral therapy (HAART) to efavirenz-based HAART (SUSTIPHAR Study) (Q80142940)
Jump to navigation
Jump to search
scientific article published on 18 August 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Intracellular and plasma efavirenz concentrations in HIV-infected patients switching from successful protease inhibitor-based highly active antiretroviral therapy (HAART) to efavirenz-based HAART (SUSTIPHAR Study) |
scientific article published on 18 August 2006 |
Statements
Intracellular and plasma efavirenz concentrations in HIV-infected patients switching from successful protease inhibitor-based highly active antiretroviral therapy (HAART) to efavirenz-based HAART (SUSTIPHAR Study) (English)
Sarah Djabarouti
Dominique Breilh
Isabelle Pellegrin
Michel Lavit
Fabrice Camou
Olivier Caubet
Hervé Fleury
Marie-Claude Saux
Jean-Luc Pellegrin